WORLD-CLASS CARE, BALINESE HEART

Bali, March 9, 2026 — Sapporo Cardio Vascular Clinic (SCVC), a cardiovascular center under Hong Kong Asia Medical Group (HKAMG), has officially introduced its presence in Indonesia through a collaboration with Bali International Hospital (BIH), located in the Sanur Health and Wellness Special Economic Zone (SEZ), Bali.

This milestone was marked by the implementation of the first Charity Transcatheter Aortic Valve Implantation (TAVI) program at BIH, providing Indonesian patients access to advanced cardiovascular procedures with international medical expertise.

Through this program, two Indonesian patients were selected as charity candidates starting in December 2025. The process included comprehensive screening, pre-procedure preparation, and the surgical intervention itself.

The charity initiative represents an important milestone as it marks the first TAVI procedure performed at BIH, carried out through a collaboration of a multinational medical team. The procedure was performed by Prof. Lam Yat Yin and Prof. Su Xi from Hong Kong, together with dr. I Made Junior, Sp.JP, SubSp.Kl., IKKv(K), an interventional cardiologist from SCVC.

All medical costs for the procedures were fully covered by HKAMG as part of its Surgery Charity Program, a humanitarian initiative aimed at expanding patient access to advanced medical technologies that were previously difficult to obtain.

For patients with severe aortic stenosis, a condition characterized by the narrowing of the aortic valve, the risk of heart failure and death increases significantly if left untreated. This charity program offers new hope for patients facing such conditions. Many patients previously had limited treatment options due to the high risk associated with open-heart surgery or the need to seek treatment abroad at significant cost.

Through the collaboration between SCVC and BIH, Indonesian patients can now receive complex cardiac procedures with international standards closer to home.

Steven Tse, CEO of Hong Kong Asia Medical Group (HKAMG), stated that SCVC’s expansion into Indonesia reflects the group’s long-term commitment to strengthening access to high-quality cardiovascular care across Asia.

“For more than two decades, HKAMG has been committed to advancing cardiovascular services through the integration of medical practice, education, and research. The presence of SCVC in Indonesia represents our effort to introduce advanced medical technologies and international clinical expertise to expand access to cardiovascular care for patients across Southeast Asia.”

He added that the Charity TAVI Program reflects HKAMG’s commitment to ensuring that medical innovation can reach patients who truly need it.

“Through this Charity TAVI Program, we aim to ensure that medical innovation is not only available but also accessible to patients in need. This initiative also helps address the demand for complex cardiac care in Indonesia, allowing patients to receive treatment locally without the need to travel abroad.”

Meanwhile, Dr. Noel Yeo, Chief of Commercial & Operations of PT Pertamedika Bali Hospital, stated that the collaboration between Bali International Hospital (BIH)and SCVC represents an important step in strengthening the development of internationally standardized cardiovascular services in Indonesia.

“The introduction of the Transcatheter Aortic Valve Implantation (TAVI) procedure at Bali International Hospital marks an important milestone in expanding treatment options for patients with heart valve disease in Indonesia. The availability of this service demonstrates that complex cardiac procedures can now be performed in Bali with international standards.

At BIH, we continuously ensure the readiness of infrastructure, availability of advanced medical devices, and access to internationally standardized pharmaceuticals so that every procedure can be carried out safely and effectively. Through our collaboration with SCVC, we hope to deliver more comprehensive cardiovascular services while strengthening the development of interventional cardiology services in Indonesia.”

He further added that this initiative is also aligned with BIH’s efforts to support the development of Bali as an international healthcare destination.

TAVI: A Modern Alternative to Open-Heart Surgery

Cardiovascular disease remains the leading cause of death globally, including in Indonesia. One of the most serious conditions commonly found among the elderly population is severe aortic stenosis, a narrowing of the aortic valve that can lead to shortness of breath, chest pain, fainting, and heart failure.

As life expectancy increases, the prevalence of degenerative heart valve disease continues to rise, while not all patients are suitable candidates for open-heart surgery.

Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive procedure designed to replace the aortic valve without the need for open-heart surgery. The new valve is delivered through a catheter, typically inserted via the femoral artery in the leg. As a result, the procedure carries lower risk and allows for faster recovery compared to conventional surgery.

On average, patients can return home within 48 to 72 hours, making TAVI an important treatment option for elderly patients or those with high surgical risk.

In Indonesia, although TAVI procedures are already available, they are still performed by a limited number of hospitals. The availability of this service at Bali International Hospital is expected to expand access while further strengthening national cardiac care standards.

According to dr. I Made Junior, the service provides new hope for patients who previously had limited treatment options.

“Many patients with severe aortic stenosis present at an advanced stage and carry high risk for open-heart surgery. With TAVI, we can offer a safer and effective alternative therapy with a faster recovery process. Collaboration between international and local experts is an important step toward advancing interventional cardiology services in Indonesia.”

Commitment to Collaboration and Knowledge Transfer

Moving forward, SCVC aims to strengthen collaboration with local cardiologists through continuous knowledge transfer, multidisciplinary case discussions, and the implementation of integrated clinical standards.

With the support of HKAMG’s regional network, SCVC is committed to building internationally standardized cardiovascular services in Indonesia, enabling more patients to access complex cardiac procedures without the need to travel abroad.

Hong Kong Asia Medical Group (HKAMG) is a leading healthcare provider specializing in cardiac surgery and cardiology, with advanced medical facilities across Asia. As part of HKAMG, Sapporo Cardio Vascular Clinic (SCVC)serves as a cardiovascular center focused on minimally invasive cardiac interventions, structural heart procedures, and complex cardiac care supported by advanced technology and global collaboration.

Through continuous training programs, cutting-edge techniques, and state-of-the-art medical technology, SCVC provides modern cardiac procedures as an alternative to conventional surgery, aiming to improve clinical outcomes while delivering more precise and personalized care for patients.